Smoking and Hypoalbuminemia as Risk Factors for Postoperative Complications in Reconstructive Hand and Forearm Surgery
Aneeq S Chaudhry, Alexander J Rodriguez, Andrew Liepshutz, Pura Rodriguez de la Vega, Rupa Seetharamaiah, Marcia Varella

TL;DR
Smoking and low albumin levels are independent risk factors for complications after hand and forearm surgery, but they don't work together to worsen outcomes.
Contribution
This study identifies smoking and hypoalbuminemia as separate risk factors for postoperative complications in reconstructive hand and forearm surgery.
Findings
Smokers had a 16% higher risk of postoperative complications compared to nonsmokers.
Hypoalbuminemia increased the risk of complications by 2.5 times.
No significant interaction was found between smoking and hypoalbuminemia in causing complications.
Abstract
Background and objective Limited evidence exists regarding the synergistic effects of smoking and hypoalbuminemia on postoperative complications in hand and forearm surgery. This study aimed to investigate the association between preoperative albumin levels, smoking status, and postoperative complications in US adults undergoing reconstructive procedures. Methods We conducted a retrospective cohort analysis of 20,725 adults identified in the 2011-2021 American College of Surgeons’ National Surgical Quality Improvement Program (ACS-NSQIP) database who underwent reconstructive hand and forearm procedures corresponding to 43 Current Procedural Terminology (CPT) codes. Smoking within one year of surgery and preoperative albumin levels below 3.5 g/dL were treated as primary independent variables. Binary logistic regression models adjusted for potential confounders were used to estimate…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Characteristics | Smoking status | Albumin (g/dL) | |||||||||
| Non-smoker (n = 16,276) | Smoker (n = 4,449) | P-value | Normal (≥3.5, n = 18,288) | Low (<3.5, n = 2,437) | P-value | ||||||
| N | % | N | % | N | % | N | % | ||||
| Age group, years | <0.001 | <0.001 | |||||||||
| 18-39 | 2580 | 15.9 | 1215 | 27.3 | 3552 | 19.4 | 243 | 10.0 | |||
| 40-49 | 1960 | 12 | 801 | 18 | 2516 | 13.8 | 245 | 10.1 | |||
| 50-59 | 3181 | 19.5 | 1163 | 26.1 | 3915 | 21.4 | 429 | 17.6 | |||
| 60-69 | 3944 | 24.2 | 907 | 20.4 | 4294 | 23.5 | 557 | 22.9 | |||
| ≥70 | 4611 | 28.3 | 363 | 8.2 | 4011 | 21.9 | 963 | 39.5 | |||
| Sex | <0.001 | <0.001 | |||||||||
| Female | 10,086 | 62 | 2235 | 50.2 | 10,755 | 58.8 | 1566 | 64.3 | |||
| Male | 6190 | 38 | 2214 | 49.8 | 7533 | 35.7 | 871 | 35.7 | |||
| BMI, kg/m² | <0.001 | <0.001 | |||||||||
| <18.5 | 296 | 1.9 | 144 | 3.3 | 354 | 2.0 | 86 | 3.7 | |||
| 18.5-24.9 | 3981 | 25 | 1440 | 33 | 4717 | 26.3 | 704 | 29.9 | |||
| 25-29.9 | 5071 | 31.8 | 1337 | 30.7 | 5717 | 31.9 | 691 | 29.3 | |||
| ≥ 30 | 6578 | 41.3 | 1439 | 33 | 7143 | 39.8 | 874 | 37.1 | |||
| Race | <0.001 | 0.001 | |||||||||
| White | 12,554 | 86.9 | 3328 | 84.1 | 14,010 | 86.2 | 1872 | 87.2 | |||
| Black | 1211 | 8.4 | 485 | 12.3 | 1489 | 9.2 | 207 | 9.7 | |||
| Asian | 481 | 3.3 | 55 | 1.4 | 502 | 3.1 | 34 | 1.6 | |||
| Other | 198 | 1.4 | 88 | 2.2 | 253 | 1.6 | 33 | 1.5 | |||
| CHF | 0.078 | <0.001 | |||||||||
| No | 16,112 | 99 | 4417 | 99.3 | 18,167 | 99.3 | 2362 | 96.9 | |||
| Yes | 164 | 1 | 32 | 0.7 | 121 | 0.7 | 75 | 3.1 | |||
| COPD | <0.001 | <0.001 | |||||||||
| No | 15,655 | 96.2 | 3952 | 88.8 | 17,473 | 95.5 | 2134 | 87.6 | |||
| Yes | 621 | 3.8 | 497 | 11.2 | 815 | 4.5 | 303 | 12.4 | |||
| Hypertension | <0.001 | <0.001 | |||||||||
| No | 8804 | 54.1 | 2808 | 63.1 | 10,592 | 57.9 | 1020 | 41.9 | |||
| Yes | 7472 | 45.9 | 1641 | 36.9 | 7696 | 42.1 | 1417 | 58.2 | |||
| History of dialysis | 0.107 | <0.001 | |||||||||
| No | 16,155 | 99.3 | 4426 | 99.5 | 18,205 | 99.6 | 2376 | 97.5 | |||
| Yes | 121 | 0.7 | 23 | 0.5 | 83 | 0.5 | 61 | 2.5 | |||
| Cancer | 0.023 | <0.001 | |||||||||
| No | 16,189 | 99.5 | 4437 | 99.7 | 18,220 | 99.6 | 2406 | 98.7 | |||
| Yes | 87 | 0.5 | 12 | 0.3 | 68 | 0.4 | 31 | 1.3 | |||
| History of bleeding disorders | <0.001 | <0.001 | |||||||||
| No | 15,621 | 96 | 4328 | 97.3 | 17,737 | 97.0 | 2212 | 90.8 | |||
| Yes | 655 | 4 | 121 | 2.7 | 551 | 3.0 | 225 | 9.2 | |||
| Preoperative systemic sepsis | <0.001 | <0.001 | |||||||||
| No | 15,893 | 97.7 | 4289 | 96.4 | 17,951 | 98.2 | 2231 | 91.6 | |||
| Yes | 383 | 2.4 | 160 | 3.6 | 337 | 1.8 | 206 | 8.5 | |||
| History of diabetes | <0.001 | <0.001 | |||||||||
| No | 13,760 | 84.5 | 3921 | 88.1 | 15,757 | 86.2 | 1924 | 79.0 | |||
| Yes | 2516 | 15.5 | 528 | 11.9 | 2531 | 13.8 | 513 | 21.1 | |||
| Functional health status | 0.005 | <0.001 | |||||||||
| Independent | 15,570 | 96.9 | 4280 | 97.7 | 17,691 | 98.0 | 2159 | 90.2 | |||
| Dependent | 499 | 3.1 | 101 | 2.3 | 364 | 2.0 | 236 | 9.9 | |||
| History of immunosuppressive therapy | <0.001 | <0.001 | |||||||||
| No | 15,490 | 95.2 | 4305 | 96.8 | 17,567 | 96.1 | 2228 | 91.4 | |||
| Yes | 786 | 4.8 | 144 | 3.2 | 721 | 3.9 | 209 | 8.6 | |||
| Hematocrit*, % | 0.699 | <0.001 | |||||||||
| Normal | 10,990 | 71.7 | 3051 | 72 | 13,161 | 76.6 | 880 | 36.8 | |||
| Low | 4340 | 28.3 | 1187 | 28 | 4013 | 23.4 | 1514 | 63.2 | |||
| Characteristics | Occurrence of any complications | P-value | |||
| No (n = 16357) | Yes (n = 4368) | ||||
| N | % | N | % | ||
| Smoking status | 0.167 | ||||
| No | 12,879 | 79.1 | 3397 | 20.9 | |
| Yes | 3478 | 78.2 | 971 | 21.8 | |
| Albumin, g/dL | <0.001 | ||||
| ≥3.5 | 15,141 | 82.8 | 3147 | 17.2 | |
| <3.5 | 1216 | 49.9 | 1221 | 50.1 | |
| Age group, years | <0.001 | ||||
| 18-39 | 3264 | 86.0 | 531 | 14.0 | |
| 40-49 | 2340 | 84.8 | 421 | 15.3 | |
| 50-59 | 3600 | 82.9 | 744 | 17.1 | |
| 60-69 | 3928 | 81.0 | 923 | 19.0 | |
| ≥70 | 3225 | 64.8 | 1749 | 35.2 | |
| Sex | 0.016 | ||||
| Female | 9655 | 78.4 | 2666 | 21.6 | |
| Male | 6702 | 79.8 | 1702 | 20.3 | |
| BMI, kg/m² | <0.001 | ||||
| <18.5 | 298 | 67.7 | 142 | 32.3 | |
| 18.5-24.9 | 4186 | 77.2 | 1235 | 22.8 | |
| 25-29.9 | 5124 | 80.0 | 1284 | 20.0 | |
| ≥30 | 6516 | 81.3 | 1501 | 18.7 | |
| Race | <0.001 | ||||
| White | 12,551 | 79.0 | 3331 | 21.0 | |
| Black | 1401 | 82.6 | 295 | 17.4 | |
| Asian | 449 | 83.8 | 87 | 16.2 | |
| Other | 223 | 78.0 | 63 | 22.0 | |
| CHF | <0.001 | ||||
| No | 16,261 | 79.2 | 4268 | 20.8 | |
| Yes | 96 | 49.0 | 100 | 51.0 | |
| COPD | <0.001 | ||||
| No | 15,649 | 79.8 | 3958 | 20.2 | |
| Yes | 708 | 63.3 | 410 | 36.7 | |
| Hypertension | <0.001 | ||||
| No | 9574 | 82.5 | 2038 | 17.6 | |
| Yes | 6783 | 74.4 | 2330 | 25.6 | |
| History of dialysis | <0.001 | ||||
| No | 16,289 | 79.2 | 4292 | 20.9 | |
| Yes | 68 | 47.2 | 76 | 52.8 | |
| Cancer | <0.001 | ||||
| No | 16,298 | 79.0 | 4328 | 21.0 | |
| Yes | 59 | 59.6 | 40 | 40.4 | |
| History of bleeding disorders | <0.001 | ||||
| No | 15,960 | 80.0 | 3989 | 20.0 | |
| Yes | 397 | 51.2 | 379 | 48.8 | |
| Preoperative systemic sepsis | <0.001 | ||||
| No | 16,240 | 80.5 | 3942 | 19.5 | |
| Yes | 117 | 21.6 | 426 | 78.5 | |
| History of diabetes | <0.001 | ||||
| No | 14,097 | 79.7 | 3584 | 20.3 | |
| Yes | 2260 | 74.2 | 784 | 25.8 | |
| Functional health status | <0.001 | ||||
| Independent | 15,869 | 79.9 | 3981 | 20.1 | |
| Dependent | 265 | 44.2 | 335 | 55.8 | |
| History of immunosuppressive therapy | <0.001 | ||||
| No | 15,723 | 79.4 | 4072 | 20.6 | |
| Yes | 634 | 68.2 | 296 | 31.8 | |
| Hematocrit*,% | <0.001 | ||||
| Normal | 11,905 | 84.8 | 2136 | 15.2 | |
| Low | 3356 | 60.7 | 2171 | 39.3 | |
| N | % | |
| Death | 52 | 0.25 |
| Major complications | 4195 | 20.0 |
| Organ space infection | 66 | 0.32 |
| Sepsis | 111 | 0.54 |
| Septic shock | 21 | 0.1 |
| Deep surgical site infection | 48 | 0.23 |
| Wound dehiscence | 48 | 0.23 |
| Pulmonary embolism | 20 | 0.1 |
| Ventilator >48 hours | 12 | 0.06 |
| Unplanned intubation | 22 | 0.11 |
| CVA/stroke with neurological deficit | 11 | 0.05 |
| Return to the operating room | 315 | 1.52 |
| Myocardial infarction | 19 | 0.09 |
| Readmission | 549 | 2.65 |
| Cardiac arrest requiring CPR | 20 | 0.1 |
| Postoperative dialysis | 2 | 0.01 |
| Length of hospital stay >2 days | 3714 | 17.92 |
| Minor complications | 463 | 2.23 |
| Pneumonia | 74 | 0.36 |
| Superficial surgical site infection | 191 | 0.92 |
| Urinary tract infection | 106 | 0.5 |
| DVT/thrombophlebitis | 18 | 0.09 |
| Bleeding transfusions | 102 | 0.49 |
| Composite outcomes* | 4368 | 21.08 |
| Characteristics | Unadjusted model | Adjusted model 1 with interaction term | Adjusted model 2 without interaction term | |||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Smoking status | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 1.06 (0.98-1.15) | 0.167 | 1.12 (1.00-1.26) | 0.052 | 1.16 (1.04-1.29) | 0.007 |
| Albumin, g/dL | ||||||
| ≥3.5 | Reference | Reference | Reference | |||
| <3.5 | 4.83 (4.42-5.28) | <0.001 | 2.42 (2.13-2.74) | <0.001 | 2.51 (2.25-2.80) | <0.001 |
| Smoking x Albumin <3.5 g/dL | 1.17 (.91-1.49) | 0.227 | - | - | ||
| Age group, years | ||||||
| 18-39 | Reference | Reference | Reference | |||
| 40-49 | 1.11 (0.96-1.27) | 0.154 | 1.01 (0.85-1.19) | 0.933 | 1.01 (.85-1.19) | 0.909 |
| 50-59 | 1.27 (1.13-1.43) | <0.001 | 1.12 (0.96-1.30 | 0.15 | 1.12 (0.97-1.30) | 0.134 |
| 60-69 | 1.44 (1.29-1.62) | <0.001 | 1.15 (0.99-1.34) | 0.063 | 1.16 (1.00-1.34) | 0.057 |
| ≥70 | 3.33 (2.99-3.72) | <0.001 | 2.11 (1.81-2.45) | <0.001 | 2.11 (1.81-2.46) | <0.001 |
| Sex | ||||||
| Female | 1.09 (1.02-1.16) | 0.016 | 1.03 (0.94-1.13) | 0.536 | 1.03 (0.94-1.12) | 0.541 |
| Male | Reference | Reference | Reference | |||
| BMI, kg/m² | ||||||
| <18.5 | 1.62 (1.31-1.99) | <0.001 | 1.21 (0.94-1.57) | 0.141 | 1.21 (0.94-1.57) | 0.139 |
| 18.5-24.9 | Reference | Reference | Reference | |||
| 25-29.9 | 0.85 (0.780-0.93) | <0.001 | 0.95 (0.86-1.06) | 0.366 | 0.95 (0.86-1.06) | 0.369 |
| ≥30 | 0.78 (0.72-0.85) | <0.001 | 0.92 (0.83-1.03) | 0.143 | 0.92 (0.83-1.03) | 0.14 |
| Race | ||||||
| White | Reference | Reference | Reference | |||
| Black | 0.79 (0.70-0.90) | 0.001 | 0.80 (0.69-0.94) | 0.005 | 0.80 (0.69-0.94) | 0.005 |
| Asian | 0.73 (0.58-0.92) | 0.008 | 0.71 (0.54-0.93 | 0.012 | 0.71 (0.54-0.93) | 0.012 |
| Other | 1.06 (0.80-1.41) | 0.664 | 1.16 (0.83-1.60) | 0.368 | 1.16 (0.84-1.61) | 0.361 |
| CHF | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 3.97 (2.99-5.26) | <0.001 | 1.67 (1.17-2.37) | 0.004 | 1.66 (1.17-2.37) | 0.005 |
| COPD | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 2.29 (2.02-2.60) | <0.001 | 1.28 (1.09-1.50) | 0.003 | 1.28 (1.09-1.5) | 0.003 |
| Hypertension | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 1.61 (1.51-1.73) | <0.001 | 1.03 (0.94-1.14) | 0.483 | 1.03 (0.94-1.13) | 0.495 |
| History of dialysis | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 4.24 (3.05-5.89) | <0.001 | 1.93 (1.29-2.88) | 0.001 | 1.92 (1.28-2.87) | 0.001 |
| Disseminated cancer | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 2.55 (1.71-3.82) | <0.001 | 1.32 (0.82-2.13) | 0.255 | 1.31 (0.81-2.11) | 0.268 |
| History of bleeding disorders | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 3.82 (3.30-4.42) | <0.001 | 2.12 (1.77-2.53) | <0.001 | 2.12 (1.78-2.53) | <0.001 |
| Preoperative systemic sepsis | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 15.00 (12.19-18.46) | <0.001 | 11.98 (9.37-15.30) | <0.001 | 11.99 (9.38-15.31) | <0.001 |
| History of diabetes | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 1.36 (1.25-1.49) | <0.001 | 1.02 (0.91-1.14) | 0.756 | 1.02 (0.91-1.14) | 0.76 |
| Functional health status | ||||||
| Independent | Reference | Reference | Reference | |||
| Dependent | 5.04 (4.27-5.94) | <0.001 | 2.21 (1.81-2.70) | <0.001 | 2.21 (1.80-2.70) | <0.001 |
| Hematocrit*, % | ||||||
| Normal | Reference | Reference | Reference | |||
| Low | 3.61 (3.36-3.87) | <0.001 | 2.49 (2.28-2.72) | <0.001 | 2.49 (2.28-2.72) | <0.001 |
| History of immunosuppressive therapy | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 1.80 (1.56-2.08) | <0.001 | 1.15 (0.96-1.37) | 0.142 | 1.14 (0.95-1.37) | 0.148 |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsReconstructive Surgery and Microvascular Techniques · Nutrition and Health in Aging · Inflammatory Biomarkers in Disease Prognosis
Introduction
Reconstructive hand surgery is becoming increasingly popular in the United States. According to the 2020 Plastic Surgery Statistics Report from the American Society of Plastic Surgeons, hand surgery ranked fifth among reconstructive procedures. The common operations include arthroplasty, tendon and nerve repair, skin grafts, and surgical debridement. In 2020, a total of 206,928 hand surgeries were performed, representing a 1% increase compared to 2019 [1].
Complications within 30 days of hand surgery occur in 2.5% of cases, with surgical site infection being the most common [2]. Despite the low incidence, such complications can greatly affect patients and healthcare resources, potentially leading to longer hospital stays, reoperations, higher infection risks, and other iatrogenic problems [2]. In addition to patient-level health impacts, complications also have negative economic implications for patients, hospitals, and healthcare systems. Estimated mean hospital costs for patients with complications (19,626 (119%) higher than for those without complications (16,434) [[3](#REF3)]. Risk adjustment analyses have shown that the overall profit margin of healthcare institutions decreases from 5.8% for patients without complications to 0.1% for patients with complications [[3](#REF3)]. For hand arthroplasty specifically, each complication was estimated to increase costs by an average of 1,076 [4].
Studies have evaluated risk factors associated with complications in reconstructive surgical procedures and findings suggest that history of comorbidities such as hypertension, diabetes, congestive heart failure, functional status, end stage renal disease, chronic obstructive pulmonary disease, anemia, as well as behavior factors such as smoking status, excessive alcohol consumption, sedentary habits, and smoking status were associated with increased risk of postoperative complications [5,6].
While several studies have analyzed the effects of cigarette smoking and hypoalbuminemia on common plastic surgical and orthopedic procedures, studies focused on surgical procedures involving the upper extremity are less common. With the increasing prevalence of elective surgical procedures involving the hand and forearm, we focused our attention on how common risk factors, smoking cigarettes and malnutrition, can impact the rate of postoperative complications. Moreover, the current literature does not adequately address the interaction between these two common risk factors. Given the similarities in the underlying pathophysiology of cigarette smoking and low serum albumin, potential synergistic effects are plausible. However, evidence remains limited regarding such combined effects and their influence on postoperative complications following hand and forearm surgery.
The objective of this study was to examine whether smoking and hypoalbuminemia are independently associated with postoperative complications following hand and forearm surgery in adults aged 18-90 years using data from a large national surgical database from 2011 to 2021. The primary outcome was a composite of postoperative complications, and the secondary objective was to assess for a potential interaction between smoking and hypoalbuminemia. We hypothesized that both smoking and hypoalbuminemia would be associated with increased odds of postoperative complications, and that their combined presence might further amplify this risk.
Materials and methods
All analyses were based on deidentified data from the American College of Surgeons’ National Surgical Quality Improvement Program (ACS-NSQIP). The Institutional Review Board of Florida International University’s Herbert Wertheim College of Medicine determined that this study is exempt from review, as it does not meet the definition of human subjects research and involves only deidentified data.
Study design
We employed a retrospective cohort study using data from the ACS NSQIP database. The ACS NSQIP database gathers data from patients who undergo surgical procedures in both outpatient and inpatient settings through a direct review of their medical charts. This comprehensive data collection process spans the preoperative and intraoperative periods, as well as up to 30 days postoperatively.
Study population
Inclusion criteria required adult participants (ages 18-90) who had any of the relevant Current Procedural Terminology (CPT) codes recorded in the ACS NSQIP database from 2011 to 2021. Eligible procedures included tendon repair, arthroscopy/arthroplasty, peripheral nerve repair, drainage or foreign body removal, bone procedures, skin grafts, and debridement. A total of 43 CPT codes were included: 25000, 25320, 26356, 26370, 26410, 26418, 26426, 26442, 26460, 26500, 26502, 25332, 29844, 29846, 64713, 64831, 25040, 25076, 25111, 24666, 25035, 24363, 24587, 24615, 24685, 25400, 25405, 25440, 25545, 25574, 25607, 25608, 25609, 25628, 26735, 26746, 26765, 24105, 24201, 24341, 24342, 26615, and 26727 (Appendix 1).
For this analysis, forearm procedures were defined as those involving the distal portion of the upper extremity, including the forearm itself and extending proximally to the level of the elbow. Procedures involving the proximal arm or shoulder were not included. This definition ensured inclusion of reconstructive surgeries commonly classified as hand and forearm procedures in both orthopedic and plastic surgery practice.
Variables
The main independent variables were patient smoking status (a dichotomous variable, defined as cigarette use within one year of reconstructive hand surgery) and preoperative hypoalbuminemia, defined as a serum albumin level below 3.5 g/dL based on prior studies [17]. Additional covariates included age (measured in years), race (as recorded in the medical record), gender, and comorbidities. Comorbidities assessed were diabetes, hypertension, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), dialysis, ventilator dependence, functional health status before surgery, disseminated cancer, immunosuppressive therapy, bleeding disorders, and systemic sepsis within 48 hours before surgery. All variables were obtained from the ACS NSQIP database.
Outcome measures
The main study outcome was a composite measure, defined as the occurrence of any selected major or minor postoperative complications within 30 days after surgery. Major complications include organ space infection, sepsis, septic shock, deep infection, wound dehiscence, pulmonary embolism, ventilator greater than 48 hours, reintubation, unplanned intubation, acute renal failure, cardiac arrest, myocardial infarction, stroke, coma greater than 24 hours, graft/prosthesis failure, peripheral injury, return to OR, unplanned reoperation, readmission, and length of hospital stay greater than two days. Length of stay greater than two days was included in the composite outcome as defined by NSQIP.
Although non-clinical factors can affect discharge timing, prior studies confirm that the procedures in our cohort are routinely performed as outpatient cases. Newman et al. reported a mean stay of 0.75 days for healthy patients undergoing distal radius fixation, with longer stays associated with increased complications [18]. Similarly, Donato et al. found that unplanned admissions or extended stays after outpatient hand surgery were uncommon and often linked to postoperative issues [19]. Minor complications include superficial surgical site infection, pneumonia, urinary tract infection, deep venous thrombosis, transfusion, and progressive renal failure. Secondary outcomes included the occurrence of all-cause mortality within 30 days of surgery, as well as the occurrence of major complications and minor complications assessed separately.
Statistical analysis
Stata software version 15.0 (StataCorp, College Station, TX) was used for all analyses. Descriptive statistics were used to summarize baseline characteristics. Bivariate analyses were performed using chi-square tests for categorical variables and t-tests for continuous variables. Multivariable logistic regression was used to examine the association between smoking, hypoalbuminemia, and 30-day postoperative complications, adjusting for demographic and clinical covariates. An interaction term between smoking and hypoalbuminemia was included to assess potential synergistic effects. Odds ratios (OR) with 95% confidence intervals (CI) were reported, and statistical significance was set at p<0.05.
Results
A total of 105,488 patients from the ACS NSQIP were initially identified as having undergone reconstructive procedures of the hand and forearm. Of these patients, 57 were excluded due to missing complication data, and 84,742 were excluded for lacking records of preoperative albumin levels. This resulted in a final analytical sample of 20,725 patients, with 3661 (21.7%) having reported active smoking and 2037 (12.1%) having an albumin level below 3.5 g/dL (hypoalbuminemia).
The patient’s characteristics varied significantly by smoking status and albumin levels (Table 1). Smokers were younger, with a higher proportion aged 18-39 years (27.3% vs. 15.9%) and were more likely to be males (49.8% vs. 38%) compared to non-smokers. Additionally, the smokers group had a higher proportion of participants with a history of COPD than non-smokers (11.2% vs. 3.8%). Concerning albumin levels, those with low levels (<3.5 g/dL) were more likely to be older (39.5% aged ≥70), female (64.3%), have hypertension (58.2%), and have bleeding disorders (9.2%) compared to those with normal levels (≥3.5 g/dL).
Complications occurred in 21.1% of the patient population who underwent hand and forearm surgery (Table 2). Overall, patients with preoperative systemic sepsis had the highest observed complication rate, with 78.5% experiencing a postoperative complication. Patients with hypoalbuminemia (<3.5 g/dL) had higher complication rates compared to those without hypoalbuminemia (50.1% vs. 17.2%). The complication rates in older patients were greater than the rates in younger patients. Higher complication rates were also found in those with CHF, COPD, hypertension, low hematocrit, decreased functional status, history of immunosuppressive therapy, history of bleeding disorders, and history of dialysis.
The overall composite complication rate included major complications, minor complications, and death (Table 3). Major complications occurred in 20.0% of patients, with the most frequent (17.9%) being extended hospital stay (length of hospital stay >2 days). The next most frequent major complications were readmission (2.7%) and return to the operating room (1.5%). Minor complications accounted for 2.2% of total complications. These included pneumonia, superficial surgical site infection, urinary tract infection, deep vein thrombosis/thrombophlebitis, and bleeding transfusions. The most frequent minor complications were superficial surgical site infection at 0.9% and bleeding transfusions at 0.5%. There were 52 deaths (0.25%) within 30 days postoperatively.
In unadjusted models, hypoalbuminemia was associated with approximately a fivefold increase in the odds of complications (OR: 4.83, 95% CI: 4.42-5.28, p<0.001), while smoking status was not associated with complications (OR: 1.06, 95% CI: 0.98-1.15, p = 0.167) (Table 4). The association of smoking with post-surgical complications was as follows: OR: 1.12 (95% CI: 1.00-1.26, p = 0.052) after adjusting for age, sex, BMI, race, comorbidities, and the interaction between smoking and albumin. Hypoalbuminemia remained significantly associated with complications (OR: 2.42, 95% CI: 2.13-2.74, p<0.001), although the strength of association was attenuated. Because the interaction between smoking and hypoalbuminemia was not significant (p = 0.227), a second adjusted model without the interaction term was tested. In this model, smoking was significantly associated with post-surgical complications (OR: 1.16, 95% CI: 1.04-1.29, p = 0.007), and hypoalbuminemia was also significantly associated with the odds of complications (OR: 2.51, 95% CI: 2.25-2.80, p<0.001).
Discussion
Smoking influencing postoperative complications following hand and forearm surgery
Of interest, smoking has been shown to increase complications in a wide array of reconstructive plastic surgeries, including craniofacial and extremities, within the first 30 days of operation [7]. However, there is limited data on the link between smoking and complications associated with hand and forearm surgery. Nicotine, the primary chemical within cigarettes, has prothrombotic and vasoconstrictive effects due to increased platelet aggregation, microangiopathy, and macroangiopathy [8,9]. Additionally, nicotine decreases the proliferation of fibroblasts and macrophages that are essential for collagen formation and wound healing, while also altering the release of catecholamines essential for perfusion and epithelialization of the wound site [8]. These compromised molecular mechanisms are essential to the wound healing processes.
Consistent with the pathophysiology described above, a meta-analysis that utilized data from nearly 500,000 patients who underwent hip and knee arthroplasty, herniotomy, cholecystectomy, and colorectal resection across 140 cohort studies reported necrosis to be four times more frequent in smokers compared to non-smokers, whereas surgical site infection, dehiscence, and delayed healing to be two times more frequent in smokers [10].
Another study assessing 36,454 patients who underwent common plastic surgery procedures from 2005-2016 and contributing to the ACS-NSQIP database found that smokers had significantly increased deep incisional surgical-site infections, incisional dehiscence, and reoperation (p<0.01 for all) [11]. Yet, for superficial surgical site infections, there were no statistically significant differences between smokers and non-smokers. Another study assessing 40,465 patients who underwent a wide variety of plastic surgery procedures from 2007 to 2012 found that smokers who had undergone hand and upper extremity-specific procedures had increased surgical complications (OR: 2.21, 95% CI: 1.39-3.42, p<0.001) and increased wound complications (OR: 2.79, 95% CI: 1.68-4.52, p<0.001) [7].
The impact of cigarette smoking on hand and upper extremity surgery has also been evaluated [5,6]. Although the overall complication rate was low (2.54%), smokers experienced higher rates of postoperative complications within 30 days. Specifically, the ORs were: 1.10 (95% CI: 0.9-1.34) for minor complications, 1.30 (95% CI: 1.06-1.60) for major complications, 1.41 (95% CI: 1.16-1.72) for wound complications [5], 1.51 (95% CI: 1.22-1.85) for superficial site infections, 1.73 (95% CI: 1.34-2.22) for deep site infections, 1.50 (95% CI: 1.24-1.80) for reoperation, and 1.49 (95% CI: 1.23-1.80) for hospital readmission [6].
Contrary to the above results, one cohort study found no significant association between smoking and increased postoperative complications [12]. In this retrospective study, the data of patients who underwent either free flap transfer procedures or replantation/revascularization procedures of the upper extremity were analyzed from the ACS NSQIP. Of the 340 total patients, 70 underwent free flap transfer, and 270 underwent replantation and/or revascularization. The results yielded no association between cigarette smoking and 30-day postoperative complications following either type of upper extremity reconstructive procedure. Potential explanations for the differences in results were the scope of procedures performed, which related to digit microvascular and free flap transfers, not including procedures related to tendon repair and bone reconstruction in the hands, wrist, and forearm. It remains unclear whether surgeries in different regions of the upper extremity are differently affected by smoking, or if the observed differences are simply due to random variation, possibly related to smaller sample sizes.
Hypoalbuminemia and postoperative complications following hand and forearm surgery
Hypoalbuminemia has been previously found to be associated with post-surgical complications [13]. In retrospective cohort studies [14,15], patients undergoing surgery of the distal radius (open reduction and internal fixation) who were malnourished and for whom serum albumin was less than 3.5 g/dL had higher incidences of post-surgery complications when compared to patients with albumin levels within the reference range (OR: 4.8,; 95% CI: 2.47-9.66; p<0.05). Malnourished patients were also shown to have significantly longer hospital stays and an increased risk of 30-day postoperative morbidity and mortality [14], even after adjustment for patients’ history of diabetes, anemia, end-stage renal disease, chronic obstructive pulmonary disease, congestive heart failure, hypertension, BMI, and smoking status. Patients with hypoalbuminemia were found to have a higher risk of death (adjusted RR: 1.67, 95% CI: 1.07-2.62), development of minor complications (adjusted RR: 16.9, 95% CI: 5.40-52.68), and development of major complications (adjusted RR: 8.29, 95% CI: 5.20-13.21) [15]. Additionally, those with hypoalbuminemia showed increased rates of sepsis/septic shock, deep infection, ventilator requirement, and reintubation following hand surgery.
Potential for interaction between smoking and hypoalbuminemia on postoperative complications
Patients who had undergone cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy had the highest morbidity and mortality in those with lower serum albumin levels and positive smoking history (OR: 3.3, 95% CI: 1.5-7.5, p<0.003) [16]. Yet, the interaction between these factors was not assessed. Wilson et al. analyzed the effects of malnutrition and postoperative complications following distal radius fracture surgeries and found that smoking status did not affect albumin level availability [14].
Our findings highlight the strong association between hypoalbuminemia and postoperative complications following reconstructive hand and forearm surgery. The twofold increase in the odds of complications associated with hypoalbuminemia (<3.5 g/dL) reflects its role as a critical predictor of surgical risk. This result aligns with prior studies linking hypoalbuminemia to poor wound healing, increased infection rates, and prolonged hospital stays, likely due to its association with systemic inflammation and malnutrition. For instance, Luchetti et al. found that patients with hypoalbuminemia had a significantly increased risk of major complications (adjusted RR: 8.29, 95% CI: 5.20-13.21), minor complications (adjusted RR: 16.9, 95% CI: 5.40-52.68), and mortality (adjusted RR: 1.67, 95% CI: 1.07-2.62) after hand surgery. The twofold increase in the odds of complications associated with hypoalbuminemia (<3.5 g/dL) reflects its role as a critical predictor of surgical risk [15]. Similarly, Wilson et al. reported a fourfold increase in complications (OR: 4.88, 95% CI: 2.47-9.66) and a ninefold increase in mortality (OR: 9.23, 95% CI: 1.55-54.87) among orthopedic patients with albumin <3.5 g/dL [14].
Notably, length of stay >2 days was the most common major complication, reinforcing the clinical and economic burden associated with postoperative morbidity. Secondary outcomes, including readmissions, return to the operating room, and superficial surgical site infections, were more frequent in patients with complications. Adjusted analyses indicated an OR of 1.12 (95% CI: 1.00-1.26, p = 0.052) of complications also for patients who smoke. However, results showed a lack of significance for the interaction between smoking and hypoalbuminemia (p = 0.227), suggesting that these factors do not have a synergistic effect.
Of note, the small sample size of patients with both smoking exposure and low albumin levels limits the power to detect such interactions. Although the odds ratio for smoking was modest (OR: 1.16, p = 0.007) in the final adjusted model, even small increases in risk may be clinically meaningful at the population level, given the high prevalence of smoking. This finding supports the value of smoking cessation interventions as part of preoperative optimization, even for lower-risk procedures such as outpatient hand surgery. Nonetheless, larger studies are needed to further investigate this potential interaction.
This study contributes to the growing body of evidence on risk stratification in upper extremity surgery, highlighting hypoalbuminemia as a potentially modifiable risk factor. Preoperative nutritional interventions, including albumin supplementation and dietary optimization, may improve outcomes. Despite the limitations imposed by the exclusion of patients without albumin data, sensitivity analyses showed that demographic and comorbidity profiles were statistically comparable between patients with and without albumin data, based on our multivariable models adjusted for age, BMI, comorbidities, and smoking. Importantly, our results align with prior NSQIP analyses, such as the study by Luchetti et al, which employed generalized linear mixed modeling to account for procedural variability and likewise demonstrated that hypoalbuminemia is independently associated with increased complications after hand surgery [15]. Taken together, these findings underscore the consistency of our results within the broader literature on hypoalbuminemia as a surgical risk factor.
Limitations
A major limitation of this study relates to the large proportion of patients with missing data on preoperative albumin levels or smoking who were not analyzed. Of those patients excluded, 20.3% reported smoking and 10.5% reported an albumin level below 3.5 g/dl. Comparisons of characteristics in participants who were excluded demonstrated no apparent differences compared to the analytical sample, including no differences in the frequency of smoking status or the prevalence of hypoalbuminemia (Appendix 2, Table 6). However, the low percentage of patients for whom pre-op albumin levels records were available raises the possibility that albumin is not routinely measured preoperatively. A total of 84,742 patients (80.3%) were excluded for this reason, and patients without albumin measurements may differ systematically in their postoperative risk compared to those with recorded values.
While our analytical cohort remained robust in size, the absence of albumin data in the broader population may introduce selection bias and limit generalizability. Although the proportion of missing albumin values is considerable, it aligns with limitations reported in other national database studies. For example, Donato et al. also encountered a substantial amount of incomplete laboratory data in their analysis of outpatient hand surgery using the NSQIP [19]. Encouraging more consistent nutritional evaluation before surgery may strengthen future studies and improve perioperative risk stratification. As such, selection bias and concerns regarding the external validity of our findings cannot be excluded. Further studies using a sample for which key variables are systematically collected are still warranted.
Another limitation stems from the lack of details on key variables. For instance, the ACS-NSQIP data only provides self-reported information on whether patients have smoked within the past year. Characterization of smoking, such as cigarette dose (pack-years) and use of other nicotine-containing products, was not available. Such information is key to providing more precise and valid exposure data.
Lastly, the NSQIP database was not designed to systematically capture complications related more specifically to hand and forearm surgeries, such as prosthesis rejection or skin necrosis, nor did it include variables that could further confound the associations we report, such as chronic disease burden. Follow-up was limited to 30 days postoperatively. Therefore, the impact of the exposures assessed on long-term complications could not be evaluated. These limitations may have led to underestimation of complication rates and potential residual confounding. Despite these limitations, the NSQIP provided one of the largest nationwide cohorts of patients undergoing hand and forearm surgery, likely representative of the U.S. surgical population.
Conclusions
In this exploratory analysis, hypoalbuminemia and smoking were both independently associated with postoperative complications in hand and forearm reconstructive surgery. Hypoalbuminemia was found to be a robust predictor of complications in hand and forearm reconstructive surgery, whereas smoking status showed a less pronounced effect. Future research should aim to further clarify the combined impact of smoking and hypoalbuminemia and refine predictive models for surgical risk assessment in larger longitudinal studies. Addressing nutritional deficiencies preoperatively is a practical strategy for enhancing patient outcomes.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1American Society of Plastic Surgeons. Plastic surgery statistics 6 2023 2020 https://www.plasticsurgery.org/news/plastic-surgery-statistics
- 2Complications within 30 days of hand surgery: an analysis of 10,646 patients J Hand Surg Am Lipira AB Sood RF Tatman PD Davis JI Morrison SD Ko JH 185218594020152623519110.1016/j.jhsa.2015.06.103 · doi ↗ · pubmed ↗
- 3Hospital and payer costs associated with surgical complications JAMA Surg Healy MA Mullard AJ Campbell DA Jr Dimick JB 82383015120162716835610.1001/jamasurg.2016.0773 · doi ↗ · pubmed ↗
- 4National prevalence of complications and cost of small joint arthroplasty for hand osteoarthritis and post-traumatic arthritis J Hand Surg Am Billig JI Nasser JS Chung KC 55345202010.1016/j.jhsa.2019.11.00231924436 · doi ↗ · pubmed ↗
- 5The impact of smoking on early postoperative complications in hand surgery J Hand Surg Am Cho BH Aziz KT Giladi AM 33646202110.1016/j.jhsa.2020.07.01432868099 · doi ↗ · pubmed ↗
- 6Effect of smoking on short-term postoperative complications after elective upper extremity surgery Hand (N Y) Del Core MA Ahn J Golden AS Bass RL Sammer D Koehler DM 2312381720223248686210.1177/1558944720926638 PMC 8984734 · doi ↗ · pubmed ↗
- 7The association between smoking and plastic surgery outcomes in 40,465 patients: an analysis of the American College of Surgeons National Surgical Quality Improvement Program data sets Plast Reconstr Surg Goltsman D Munabi NC Ascherman JA 50351113920172812189710.1097/PRS.0000000000002958 · doi ↗ · pubmed ↗
- 8Smoking and hand surgery J Hand Surg Am Wei DH Strauch RJ 1761793820132314104810.1016/j.jhsa.2012.08.018 · doi ↗ · pubmed ↗
